Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
TAC T-cells for the Treatment of HER2-positive Solid Tumors - Drug Trials For Money - Paid Clinical Trials

TAC T-cells for the Treatment of HER2-positive Solid Tumors

TAC T-cells for the Treatment of HER2-positive Solid Tumors
Condition:   HER2-Positive Solid Tumors
Intervention:   Biological: TAC01-HER2
Sponsor:   Triumvira Immunologics, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 28, 2021 / by / in
Comments